62 related articles for article (PubMed ID: 19820364)
1. Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer.
Michelsen TM; Dørum A; Tropé CG; Fosså SD; Dahl AA
Int J Gynecol Cancer; 2009 Aug; 19(6):1029-36. PubMed ID: 19820364
[TBL] [Abstract][Full Text] [Related]
2. Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants.
Choi YH; Terry MB; Daly MB; MacInnis RJ; Hopper JL; Colonna S; Buys SS; Andrulis IL; John EM; Kurian AW; Briollais L
JAMA Oncol; 2021 Apr; 7(4):585-592. PubMed ID: 33630024
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after risk-reducing salpingo-oophorectomy in women with a pathogenic BRCA variant.
Zilski N; Speiser D; Bartley J; Roehle R; Blohmer JU; Keilholz U; Goerling U
J Sex Med; 2023 Dec; 21(1):33-39. PubMed ID: 37973412
[TBL] [Abstract][Full Text] [Related]
4. Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.
Chai X; Friebel TM; Singer CF; Evans DG; Lynch HT; Isaacs C; Garber JE; Neuhausen SL; Matloff E; Eeles R; Tung N; Weitzel JN; Couch FJ; Hulick PJ; Ganz PA; Daly MB; Olopade OI; Tomlinson G; Blum JL; Domchek SM; Chen J; Rebbeck TR
Breast Cancer Res Treat; 2014 Nov; 148(2):397-406. PubMed ID: 25311111
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.
Terra L; Lee Meeuw Kjoe PR; Agelink van Rentergem JA; Beekman MJ; Heemskerk-Gerritsen BAM; van Beurden M; Roeters van Lennep JE; van Doorn HC; de Hullu JA; Mourits MJE; van Dorst EBL; Mom CH; Slangen BFM; Gaarenstroom KN; van der Kolk LE; Collée JM; Wevers MR; Ausems MGEM; van Engelen K; van de Beek I; Berger LPV; van Asperen CJ; Gomez Garcia EB; Maas AHEM; Hooning MJ; van der Wall E; van Leeuwen FE; Schagen SB
BJOG; 2023 Jul; 130(8):968-977. PubMed ID: 36715559
[TBL] [Abstract][Full Text] [Related]
6. Urinary incontinence more than 15 years after premenopausal risk-reducing salpingo-oophorectomy: a multicentre cross-sectional study.
Terra L; Heemskerk-Gerritsen BAM; Beekman MJ; Engelhardt E; Mourits MJE; van Doorn HC; de Hullu JA; Mom CH; Slangen BFM; Gaarenstroom KN; van Beurden M; Roeters Van Lennep JE; van Dorst EBL; van der Kolk LE; Collée JM; Wevers MR; Ausems MGEM; van Engelen K; van de Beek I; Berger LPV; van Asperen CJ; Gomez Garcia EB; Maas AHEM; Hooning MJ; Steensma AB; van Leeuwen FE
BJOG; 2024 Jan; 131(1):99-108. PubMed ID: 37394722
[TBL] [Abstract][Full Text] [Related]
7. The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review.
Siyam T; Ross S; Campbell S; Eurich DT; Yuksel N
BMC Womens Health; 2017 Mar; 17(1):22. PubMed ID: 28320467
[TBL] [Abstract][Full Text] [Related]
8. Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis.
Manchanda R; Legood R; Antoniou AC; Gordeev VS; Menon U
J Med Genet; 2016 Sep; 53(9):591-9. PubMed ID: 27354448
[TBL] [Abstract][Full Text] [Related]
9. Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.
Nebgen DR; Domchek SM; Kotsopoulos J; de Hullu JA; Crosbie EJ; Paramanandam VS; Brood-van Zanten MMA; Norquist BM; Guise T; Rozenberg S; Kurian AW; Pederson HJ; Yuksel N; Michaelson-Cohen R; Bober SL; da Silva Filho AL; Johansen N; Guidozzi F; Evans DG; Menon U; Kingsberg SA; Powell CB; Grandi G; Marchetti C; Jacobson M; Brennan DJ; Hickey M
BJOG; 2023 Nov; 130(12):1437-1450. PubMed ID: 37132126
[TBL] [Abstract][Full Text] [Related]
10. Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c and CRP.
Vermeulen RFM; van Altena JL; Gaarenstroom KN; van Beurden M; Kieffer JK; Aaronson NK; Kenter GG; Korse CM
Climacteric; 2023 Oct; 26(5):489-496. PubMed ID: 37288958
[TBL] [Abstract][Full Text] [Related]
11. Risk-reducing decisions regarding germline
Abe A; Nomura H; Fusegi A; Yunokawa M; Ueki A; Habano E; Arakawa H; Kaneko K; Minoura Y; Inari H; Ueno T; Kanao H
J Med Genet; 2024 Mar; 61(4):392-398. PubMed ID: 38124001
[TBL] [Abstract][Full Text] [Related]
12. WHAM-A Prospective Study of Weight and Body Composition After Risk-Reducing Bilateral Salpingo-oophorectomy.
Price SAL; Finch S; Krejany E; Jiang H; Kale A; Domchek S; Wrede D; Wark JD; Hickey M
J Clin Endocrinol Metab; 2023 Dec; 109(1):e397-e405. PubMed ID: 37410931
[TBL] [Abstract][Full Text] [Related]
13. Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
Joly F; Ahmed-Lecheheb D; Kalbacher E; Heutte N; Clarisse B; Grellard JM; Gernier F; Berton-Rigaud D; Tredan O; Fabbro M; Savoye AM; Kurtz JE; Alexandre J; Follana P; Delecroix V; Dohollou N; Roemer-Becuwe C; De Rauglaudre G; Lortholary A; Prulhiere K; Lesoin A; Zannetti A; N'Guyen S; Trager-Maury S; Chauvenet L; Abadie Lacourtoisie S; Gompel A; Lhommé C; Floquet A; Pautier P
Ann Oncol; 2019 May; 30(5):845-852. PubMed ID: 30851097
[TBL] [Abstract][Full Text] [Related]
14. Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline.
Jacobson M; Coakley N; Bernardini M; Branco KA; Elit L; Ferguson S; Kim R
Hered Cancer Clin Pract; 2021 Sep; 19(1):39. PubMed ID: 34565426
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported quality of life might depend on prophylactic or therapeutic surgery for women with higher genetic predisposition to breast or ovarian cancer.
Zhou J; Wu P; Zhang Y
Am J Obstet Gynecol; 2024 Feb; 230(2):273-274. PubMed ID: 37659747
[No Abstract] [Full Text] [Related]
16. Quality of life among women after surgery for ovarian cancer.
Schulman-Green D; Ercolano E; Dowd M; Schwartz P; McCorkle R
Palliat Support Care; 2008 Sep; 6(3):239-47. PubMed ID: 18662417
[TBL] [Abstract][Full Text] [Related]
17. Postsurgical physical activity and fatigue-related daily interference in women with non-metastatic breast cancer.
Stagl JM; Antoni MH; Lechner SC; Carver CS; Lewis JE
Psychol Health; 2014; 29(2):177-98. PubMed ID: 24131016
[TBL] [Abstract][Full Text] [Related]
18. Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.
Mai PL; Huang HQ; Wenzel LB; Han PK; Moser RP; Rodriguez GC; Boggess J; Rutherford TJ; Cohn DE; Kauff ND; Phillips KA; Wilkinson K; Wenham RM; Hamilton C; Powell MA; Walker JL; Greene MH; Hensley ML
Gynecol Oncol; 2020 Jan; 156(1):131-139. PubMed ID: 31759774
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Cancer Prevention in High-risk Women.
Temkin SM; Bergstrom J; Samimi G; Minasian L
Clin Obstet Gynecol; 2017 Dec; 60(4):738-757. PubMed ID: 28957949
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
